Health
BAT’s COVID-19 vaccine candidate gets FDA approval for human study – Reuters
British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug…
By Reuters Staff
Dec 16 (Reuters) – British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug Administration for Phase I human study.
The Worlds No.2 cigarette company had earlier this year said it was working on a COVID-19 vaccine using proteins extracted from tobacco leaves.
The company said the enrolment for the study is expected to begin shortly.
-
Noosa News23 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General22 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News21 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
Noosa News21 hours agoBail bid delayed for attempted murder-accused girl in Ipswich